Objective The Systemic Lupus International Collaborating Clinics (SLICC) group revised
and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (…

Objective To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic
Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting …

Objective: To develop an evidence-based guideline for the pharmacologic and nonpharmacologic
treatment of psoriatic arthritis (PsA), as a collaboration between the American College …

Background Patients who have had inadequate response to tumour necrosis factor inhibitors
have fewer treatment options and are generally more treatment refractory to subsequent …

… Ana-Maria Orbai1, … finally, OMERACT participants voted for individual domains as well as
the final core domain set (Orbai AM, de Wit M, Mease PJ, et al. Updating the psoriatic arthritic …

Purpose To evaluate the reliability and validity of 11 PROMIS measures to assess symptoms
and impacts identified as important by people with rheumatoid arthritis (RA). Methods …

Objective. To include the patient perspective in accordance with the Outcome Measures in
Rheumatology (OMERACT) Filter 2.0 in the updated Psoriatic Arthritis (PsA) Core Domain Set …

… Ana-Maria Orbai declares the receipt of grant money in the form of a Scientist Development
Award from the Rheumatology Research Foundation (RRF). Clifton O. Bingham declares the …

Background The objective was to compare different definitions of remission and low disease
activity (LDA) in patients with psoriatic arthritis (PsA), based on both patients’ and physicians…

Melanoma differentiation-associated protein 5 (MDA-5) is a novel autoantibody frequently
characterized by interstitial lung disease and a distinct cutaneous phenotype with palmar …